Downloadable PDFs and Excel tables of the Annual Report and Notice of AGM documents are available below.


Notes to the accounts

6 Taxation

 

Continuing
Year ended
31 July 2008
£m

Continuing
Period ended
31 July 2007
£m

Discontinued
Year ended
31 July 2008
£m

Discontinued
Period ended
31 July 2007
£m

The taxation charge for the year comprises

       

– current income taxation

67.0

13.6

 

87.6

– deferred taxation

8.0

39.5

2.3

0.6

Total taxation expense in the income statement

75.0

53.1

2.3

88.2

Current income taxation

       

– UK corporation tax

       

– foreign tax

67.0

13.6

 

62.6

– discontinued tax

     

25.0

 

67.0

13.6

 

87.6

 

Reconciliation of the total tax charge

The tax expense on the profit for the period is different from the standard rate of corporation tax in the UK of 29.3% (2007: 30%). The difference is reconciled as follows:

 

Continuing
Year ended
31 July 2008
£m

Continuing
Period ended
31 July 2007
£m

Discontinued
Year ended
31 July 2008
£m

Discontinued
Period ended
31 July 2007
£m

Profit before tax

319.3

256.0

26.8

1,613.4

Notional taxation expense at UK rate of 29.3% (2007: 30%)

93.7

76.8

7.9

484.0

Effect of overseas taxation

8.2

15.7

 

5.0

Compliance benefits

(12.4)

(16.5)

 

(4.0)

Local incentives

(16.1)

(16.1)

 

(7.0)

Sale of investment

 

(7.2)

   

Tax effect of other non-headline items

1.6

0.4

   

Tax effect of Aerospace sale

   

(5.6)

(389.8)

 

75.0

53.1

2.3

88.2

Comprising

       

– taxation on headline profit

91.3

86.4

   

– tax relief on non-headline loss

(16.3)

(33.3)

   

– taxation on discontinued profit

     

36.9

– tax on sale of discontinued operations

   

2.3

51.3

Total taxation expense in the income statement

75.0

53.1

2.3

88.2

 

Year ended
31 July 2008
£m

Period ended
31 July 2007
£m

Tax on items charged/(credited) to equity

   

Current tax credit

   

– share-based payment

(5.2)

(10.3)

– exchange gains

 

(2.4)

 

(5.2)

(12.7)

Deferred tax (credit)/charge

   

– retirement benefit schemes

(75.5)

30.1

– share-based payment

3.8

9.4

 

(76.9)

26.8

 

Deferred taxation

 

Excess tax
depreciation
on fixed assets
and goodwill
£m

Share-based
payment
£m

Retirement
benefit
obligations
£m

Capitalised
development
expenditure
£m

Other
£m

Total
£m

At 5 August 2006

(45.9)

24.5

32.7

(11.8)

43.1

42.6

(Charge)/credit to income statement

(41.3)

2.3

(55.6)

22.8

31.7

(40.1)

Charge to equity

 

(9.4)

(30.1)

   

(39.5)

Other

       

(1.5)

(1.5)

Disposals

12.0

   

(22.0)

27.4

17.4

Exchange adjustments

3.1

(1.7)

(2.2)

0.8

(2.9)

(2.9)

At 31 July 2007

(72.1)

15.7

(55.2)

(10.2)

97.8

(24.0)

Deferred tax assets

11.1

 

12.7

(4.4)

74.6

94.0

Deferred tax liabilities

(83.2)

15.7

(67.9)

(5.8)

23.2

(118.0)

At 31 July 2007

(72.1)

15.7

(55.2)

(10.2)

97.8

(24.0)

Credit/(charge) to income statement

9.7

0.3

(31.3)

(1.6)

12.6

(10.3)

Charge to equity

 

(3.8)

75.5

   

71.7

Other

       

6.0

6.0

Disposals

       

(12.8)

(12.8)

Exchange adjustments

(1.9)

 

0.5

(0.2)

2.9

1.3

At 31 July 2008

(64.3)

12.2

(10.5)

(12.0)

106.5

31.9

Deferred tax assets

(2.6)

0.3

19.7

(4.6)

83.4

96.2

Deferred tax liabilities

(61.7)

11.9

(30.2)

(7.4)

23.1

(64.3)

At 31 July 2008

(64.3)

12.2

(10.5)

(12.0)

106.5

31.9

 

Included in Other above is a deferred tax liability of £9.3m (2007: £10m) relating to unremitted overseas earnings. No additional tax liabilities have been recognised because the Group is in a position to control the timing of other temporary differences and it is probable that such differences will not reverse in the future. Other deferred tax also includes the tax benefits of losses carried forward amounting to £26.7m (2007: £15.4m).

The Group has not recognised deferred tax assets relating to tax losses of £102.2m (2007: £17.9m), due to uncertainty as to their recoverability. The expiry date of operating losses carried forward is dependent upon the law of the various territories in which the losses arise. A summary of expiry dates for losses in respect of which restrictions apply is set out below.

Restricted losses

 

2008
£m

Expiry of losses

2007
£m

Expiry of losses

Territory

       

– Americas

10.7

2019-2025

10.6

2019-2025

– Europe

   

5.0

2014

Total restricted losses

10.7

 

15.6

 

Unrestricted losses:

       

– operating losses

91.5

No expiry

2.3

No expiry

Total

102.2

 

17.9

 

Smiths Group divisions:
Smiths Detection, Smiths Medical, John Crane, Smiths Interconnect, Flex-Tek

 

Smiths Group plc:
Registered office 765 Finchley Road, London NW11 8DS
Incorporated in England No. 137013
Copyright 2008 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy